| Sector |
Trading
|
Compare with Sector peers |
| Industry |
Trading
|
Compare with Industry peers |
| Website | http://www.remuspharma.com | |
| Market Cap | 749.90 Cr. | |
| Enterprise Value(EV) | 757.84 Cr. | 2023-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 57.73 | Trailing Twelve Months Ending 2023-03 |
| Price-Earning Ratio (PE) | 88.19 | Trailing Twelve Months Ending 2023-03 |
| Industry PE | 49.62 | Trailing Twelve Months Ending 2023-03 |
| Book Value / Share | 396.25 | Trailing Twelve Months Ending 2023-03 |
| Price to Book Value | 12.85 | Calculated using Price: 5,090.95 |
| Dividend Yield | 0.04 | Period Ending 2022-03 |
| No. of Shares Subscribed | 0.15 Cr. | 1,473,000 Shares |
| FaceValue | 10 | |
| About Remus Pharmaceuticals Ltd. | ||
| The company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. Having cultivated strong and dependable customer relationships ranging from Generic distributors, regional distributors and Multinational distributors to Hospitals and Clinics through a responsive distribution network, its clients are spread in various countries | ||
| 1 Day |
|
+2.62% |
| 1 Week |
|
+14.75% |
| 1 Month |
|
+12.96% |
| 3 Month |
|
+52.42% |
| 6 Month |
|
|
| 1 Year |
|
|
| 2 Year |
|
|
| 5 Year |
|
|
| 10 Year |
|
| 3 years | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 40.17 | 40.49 | 71.44 | |
| Return on Capital Employed (%) | 47.76 | 48.84 | 93.20 | |
| Return on Assets (%) | 15.38 | 12.61 | 25.26 |
| Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
| Shh. Funds | 2 | 3 | 6 | 19 | |
| Non Curr. Liab. | 0 | 0 | 0 | 7 | |
| Curr. Liab. | 3 | 8 | 9 | 8 | |
| Minority Int. | |||||
| Equity & Liab. | 5 | 11 | 16 | 35 | |
| Non Curr. Assets | 1 | 3 | 8 | 23 | |
| Curr. Assets | 5 | 8 | 8 | 11 | |
| Misc. Exp. not W/O | |||||
| Total Assets | 5 | 11 | 16 | 35 |
| Particulars | 3 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Net Sales | 12 | 18 | 25 | |
| Other Income | 1 | 1 | 1 | |
| Total Income | 13 | 19 | 25 | |
| Total Expenditure | -12 | -18 | -21 | |
| PBIDT | 1 | 2 | 5 | |
| Interest | 0 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | |
| Taxation | 0 | 0 | -1 | |
| Exceptional Items | ||||
| PAT | 1 | 1 | 3 | |
| Adjusted EPS | 8 | 10 | 34 |
| Particulars | 3 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 1 | 3 | 5 | |
| Cash Fr. Inv. | -1 | -3 | -5 | |
| Cash Fr. Finan. | 0 | 0 | 0 | |
| Net Change | 1 | 0 | 0 | |
| Cash & Cash Eqvt | 1 | 1 | 1 |
|
No Corporate Announcement found. |
| Fri, 29 Sep 2023 |
Opening at Low
|
Close Within 52 Week High Zone
|
Close Above Last Week High
|
Close Above Last Month High
|
Opening at Low for 2 Days
|
Equities
M.F.
Sectors
StockEdge Social